← Leaderboards
Kang Ting
University Of California Los Angeles
$4,639,388
Attributed
$6,528,125
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $902.5K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,528,125 · 6
By mechanism
R01$4,103,264 · 2
R44$902,470 · 1
SB1$882,811 · 1
K23$487,080 · 1
R03$152,500 · 1
Top collaborators
- Jeremiah Easley5 shared
- Chia Soo1 shared
- Zhong Zheng1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Karen M. Lyons$14,588,532
- Marxa L. Figueiredo$5,304,752
- Xinli Zhang$1,249,963
- Susan Y Bookheimer$37,624,801
- Isidro B. Benjamin Salusky$22,568,917
Others in their field
Top investigators on “Osteoblasts”
- Gerard Karsenty · University Of Texas Md Anderson Can Ctr$29,617,439
- Clifford J Rosen · Icahn School Of Medicine At Mount Sinai$20,700,088
- Henry M Kronenberg · Massachusetts General Hospital$20,551,682
- Brendan Hl Lee · Baylor College Of Medicine$20,273,696
- Stavroula Kousteni · Columbia University Health Sciences$19,552,379
- Ernesto Canalis · University Of Connecticut Sch Of Med/Dnt$18,574,878
Research focus
OsteoblastsBaseCellsIn VitroRegulationCraniosynostosisPolymerase Chain ReactionOsteogenesisAffectDevelopmental NeurobiologyNorthern BlottingsMediatingInnovationIn Situ HybridizationAnimalsGene ExpressionExhibitsRecombinants3t3 CellsClinical ResearchBone RegenerationAntibodiesAnimal ModelBone
Grant awards (19)
Novel peptide-impregnated hydrogel as a wound healing device$902,470
R44 · FY2021 · DE · contact PI
Anti-scar peptide for cleft lip repair$882,811
SB1 · FY2019 · DE · contact PI
NELL-1 Systemic Therapy for Osteoporosis$508,492
R01 · FY2018 · AR · contact PI
NELL-1 Systemic Therapy for Osteoporosis$455,232
R01 · FY2017 · AR · contact PI
NELL-1 Systemic Therapy for Osteoporosis$349,666
R01 · FY2016 · AR · contact PI
NELL-1 Systemic Therapy for Osteoporosis$341,535
R01 · FY2015 · AR · contact PI
NELL-1 Systemic Therapy for Osteoporosis$337,269
R01 · FY2014 · AR · contact PI
Nell-1, A Cbfa 1 Downstream Target, In Bone Formation$400,696
R01 · FY2009 · DE · contact PI
NELL-1, A Cbfa1 DOWNSTREAM TARGET, IN BONE FORMATION$325,984
R01 · FY2008 · DE · contact PI
NELL-1, A Cbfa1 DOWNSTREAM TARGET, IN BONE FORMATION$329,610
R01 · FY2007 · DE · contact PI
NELL-1, A Cbfa1 DOWNSTREAM TARGET, IN BONE FORMATION$339,455
R01 · FY2006 · DE · contact PI
NELL-1, A Cbfa1 DOWNSTREAM TARGET, IN BONE FORMATION$347,625
R01 · FY2005 · DE
NELL-1, A Cbfa1 DOWNSTREAM TARGET, IN BONE FORMATION$367,700
R01 · FY2004 · DE
NEL-2 GENE IN BONE FORMATION &CRANIAL SUTURE CLOSURES$121,770
K23 · FY2003 · DE
Mechanistic Role of NELL-1 in Premature Suture Closure$76,250
R03 · FY2003 · DE
NEL-2 GENE IN BONE FORMATION &CRANIAL SUTURE CLOSURES$121,770
K23 · FY2002 · DE
Mechanistic Role of NELL-1 in Premature Suture Closure$76,250
R03 · FY2002 · DE
NEL-2 GENE IN BONE FORMATION &CRANIAL SUTURE CLOSURES$121,770
K23 · FY2001 · DE
NEL-2 GENE IN BONE FORMATION &CRANIAL SUTURE CLOSURES$121,770
K23 · FY2000 · DE